» Articles » PMID: 20373902

Curcumin Induces Cell Death in Human Uveal Melanoma Cells Through Mitochondrial Pathway

Overview
Journal Curr Eye Res
Publisher Informa Healthcare
Specialty Ophthalmology
Date 2010 Apr 9
PMID 20373902
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To study the cytotoxic effects and related signaling pathways of curcumin on human uveal melanoma cells in vitro.

Materials And Methods: Two human uveal melanoma cell lines (M21 and SP6.5), scleral fibroblasts, and choroidal melanocytes were treated with curcumin. The effects of curcumin on cell viability were assessed by using the MTT (3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide) assay. Cytosol cytochrome c levels and the activities of caspase-9 and caspase-3 were measured by using an enzyme-linked immunosorbent assay.

Results: Curcumin induced cell death of cultured human uveal melanoma cells in a dose-dependent manner (10, 30, and 100 microM) and time-dependent manner (3-48 hr), with IC50 at 19.05 microM and 22.39 microM in M21 and SP6.5 cell lines, respectively. Curcumin at lower concentrations (10-30 microM) selectively reduced the cell viability of uveal melanoma cells, without affecting cell viability of fibroblasts and choroidal melanocytes. Curcumin significantly increased the level of cytosol cytochrome c (2-fold greater than the controls after 2 hr treatment), caspase-9 and caspase-3 activities (approximately 4.5- and 6-fold greater than the controls after 2-6 hr treatment, respectively) in a dose-dependent manner.

Conclusions: Curcumin has selectively potent cytotoxic effects on cultured human uveal melanoma cells. This effect is associated with the release of cytochrome c from the mitochondria and the activation of caspase-9 and caspase-3 in uveal melanoma cells after treatment with curcumin.

Citing Articles

Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve.

Cheng Y, Xu Q, Yu M, Dang C, Deng L, Chen H Curr Med Chem. 2024; 32(3):447-467.

PMID: 38918994 PMC: 11826934. DOI: 10.2174/0109298673305616240610153554.


Anticarcinogenic Potency of EF24: An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery.

Sazdova I, Keremidarska-Markova M, Dimitrova D, Mitrokhin V, Kamkin A, Hadzi-Petrushev N Cancers (Basel). 2023; 15(22).

PMID: 38001739 PMC: 10670065. DOI: 10.3390/cancers15225478.


A Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma.

Xie L, Yue W, Ibrahim K, Shen J Pharmaceutics. 2021; 13(9).

PMID: 34575410 PMC: 8467666. DOI: 10.3390/pharmaceutics13091335.


Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells.

Giallongo S, Di Rosa M, Caltabiano R, Longhitano L, Reibaldi M, Distefano A Aging (Albany NY). 2020; 12(10):9745-9760.

PMID: 32401230 PMC: 7288915. DOI: 10.18632/aging.103241.


Potential of Curcumin in Skin Disorders.

Vollono L, Falconi M, Gaziano R, Iacovelli F, Dika E, Terracciano C Nutrients. 2019; 11(9).

PMID: 31509968 PMC: 6770633. DOI: 10.3390/nu11092169.